Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioCryst Pharmaceuticals Inc BCRX

Healthcare Biotechnology
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BCRX)

BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)

GlobeNewswire 1 day ago

BioCryst to Present at Upcoming Investor Conferences

GlobeNewswire 3 days ago

BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 4 days ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 7 days ago

BioCryst to Report First Quarter 2024 Financial Results on May 6

GlobeNewswire April 22, 2024

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency

GlobeNewswire April 17, 2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 3, 2024

BioCryst to Present at Upcoming Investor Conferences

GlobeNewswire March 25, 2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire March 5, 2024
View More News ››

Opinion & Analysis (NDAQ:BCRX)

The Calandra Report: Blood in streets, rivers of fortune

Thom Calandra July 24, 2015

The Calandra Report: Rapivab, MERS, Thailand & BCRX

Thom Calandra June 19, 2015

The Calandra Report: Show me a favorite, I dare you

Thom Calandra June 8, 2015

The Calandra Report: Moveable feast of pharma, not gold

Thom Calandra June 4, 2015

The Calandra Report: They're jamming In the name of the lode

Thom Calandra March 13, 2015

Ultra-Actionables: Natcore Tech, Angkor Gold, BioCryst, Vegas

Thom Calandra February 20, 2015
View More Opinion ››

Bullboard Posts (NDAQ:BCRX)

BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Ou

JUST IN: $BCRX BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance | BenzingaMonday...
whytestocks - 4 days ago

BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estim

Just In: $BCRX BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates | BenzingaBioCryst Pharmaceuticals (NASDAQ: BCRX) came...
whytestocks - 4 days ago

4 PROMISING BIOTECH STOCKS WITH IMMENSE POTENTIAL!

$BCRX $IPSC $DYAI $CDNA   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of...
AviseAnalytics - January 14, 2022

BCRX LONG!

My largest holding   Awaiting Factor D news Mar 22.  This can be life changing.   
mevani - March 17, 2021

BOOM!!!!! eom

Now we are getting noticed.  Still holding my shares.
mevani - February 1, 2021

RE:RE:This is a long term hold for me

I have been accumulatig  BCRX since the $3's  up to and including the $9's  more recently.  Seems to have...
mevani - January 22, 2021
View more Bullboard ››

Bitcoin Well Inc

Bitcoin Well Inc

Bitcoin Well Inc. is a Canada-based company engaged in the non-custodial fintech business, which future-proofs money by ...
View More »